Association of OPRK1 rs963549 and rs997917 polymorphisms with opioid use disorder and related phenotypes
To evaluate the association between rs963549 and rs997917 and opioid use disorder (OUD) and related phenotypes. A sample of 208 individuals with (n = 100) and without (n = 108) OUD were enrolled. rs963549 and rs997917 were analyzed by PCR-RFLP. Craving, opioid withdrawal and the intensity of depress...
Gespeichert in:
Veröffentlicht in: | Pharmacogenomics 2023-04, Vol.24 (6), p.325-334 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To evaluate the association between
rs963549 and rs997917 and opioid use disorder (OUD) and related phenotypes.
A sample of 208 individuals with (n = 100) and without (n = 108) OUD were enrolled.
rs963549 and rs997917 were analyzed by PCR-RFLP. Craving, opioid withdrawal and the intensity of depressive and anxiety symptoms were measured by the appropriate scales.
rs963549 variation showed a trend of association with decreased opioid withdrawal. No significant associations were found between
rs963549 and rs997917 polymorphisms and craving, depression or anxiety symptoms. Neither single
SNPs nor
haplotypes were associated with OUD.
Our results could be useful for treatment failures of individuals who experience greater opioid withdrawal due to their
rs963549 genotypes. |
---|---|
ISSN: | 1462-2416 1744-8042 |
DOI: | 10.2217/pgs-2023-0037 |